Role of Tagaradi Capsule in the management of Anidra (Insomnia)

IPGT RA GAU Jamnagar0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients of both sexes in between the age group 18-75 years.
•2. Patients suffering from following type of disturbed sleep pattern.
•1) Sleep onset insomnia (Difficulty to taking sleep at the beginning of the night)
•2) Sleep maintenance insomnia (Difficulty to maintain the sleep)
•3) Nocturnal awakening (Difficulty to returning to sleep after awakening in the middle of the night or wakening early in the morning)
•4) Rebound insomnia (Patients who has developed dependence to sedatives)
•5) Circadian rhythm disorders (Sleeping pattern changes)
•6) Patients having insomnia more than 2 weeks, less than 6 months
•3. Patients of insomnia with mild hypertension, mild depression and anxiety disorders without any complains of other major diseases.

•Patients less than 18 years and more than 75 years.
•Patients suffering from fatal familial insomnia.
•Insomnia with major psychiatric illness like, Schizophrenia, Depressive psychosis, Epilepsy, etc.
•Patients having advanced chronic illness like Bronchial asthma, Diabetes mellitus, Malignancy, Liver cirrhosis, Chronic renal failure, etc.
•Patients with alcohol or drug dependency will be excluded.
•Patients having acute illness like Cardiovascular accidents, Myocardial infarction, Chronic obstructive pulmonary disease.
•Pregnant woman and planning to be pregnant within six months.

发起方

IPGT RA GAU Jamnagar